Bixiye
QP46-26 Centers for Medicare & Medicaid Services (CMS) Program Integrity Audit
Taariikhda wax ku ool ah ee barnaamijka: Jun 24, 2026
Natiijooyinka Raadinta
Soo bandhiga 4221 - 4230 ee natiijooyinka 4303
Bixiye
Antidepressant Agents - Commercial
Step Therapy, Quantity Limit
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2026
Bixiye
Anti-Obesity Non-GLP-1 Agents - Commercial
Formulary Exception, Quantity Limit
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2026
Bixiye
Biologic Immunomodulators - BasicRx (For Pharmacy Benefits Only) - Commercial
Prior Authorization, Quantity Limit
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2026
Bixiye
Biologic Immunomodulators - FlexRx GenRx KeyRx (For Pharmacy Benefits Only) - Commercial
Prior Authorization, Quantity Limit
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2026
Bixiye
Aqvesme PAQL - Commercial
Prior Authorization, Quantity Limit
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2026
Bixiye
Aqvesme PAQL - Medicaid
Prior Authorization, Quantity Limit
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2026
Bixiye
Alpha-1 Proteinase Inhibitor PA - Medicaid
Oggolaanshaha Hore
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2026
Bixiye
Alpha-1 Proteinase Inhibitor PA - Commercial
Oggolaanshaha Hore
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2026
Bixiye
Acute Migraine Agents - Commercial
Prior Authorization, Quantity Limit
Taariikhda dhaqangalka Barnaamijka: Jul 01, 2026